Fierce Medtech

JenaValve has secured the FDA’s approval for its minimally invasive heart implant, making it the first to claim a U.S. green light to treat severe backflow through the aortic valve. fiercebiotech.com/medtech/jenava…

Stroke treatment hardware developer Imperative Care has posted a $100 million funding round to support its commercial growth and research into its upcoming robotic platform. fiercebiotech.com/medtech/stroke…

Agilent to acquire Biocare in $950M 'complementary combination' fiercebiotech.com/cro/agilent-ma…

Three diabetes tech companies made the case in Barcelona for their CGMs and insulin pumps as they look to expand their reach in Type 2 diabetes. fiercebiotech.com/medtech/insule…

Cognito Therapeutics, which is in late-stage development of its device to treat neurodegenerative diseases like Alzheimer’s, hauled in $105 million in an oversubscribed series C funding round. fiercebiotech.com/medtech/cognit…

With colon cancer deaths rising among younger adults and millions of eligible Americans skipping their colonoscopies, Guardant Health is taking its Shield blood test on the road in hopes of tackling “dangerously low” screening rates. fiercebiotech.com/medtech/guarda…

Science has added a whole lot more cash to the bank, bringing in an impressive $230 million in its latest raise. fiercebiotech.com/medtech/bci-re…

HHS bans Claude AI tool as Trump seeks full government blacklisting of Anthropic fiercebiotech.com/ai-and-machine…

MindMaze seeks 'strategic alternatives,' eyes US expansion as 2 board members exit fiercebiotech.com/medtech/mindma…

Quantum Surgical is looking to become the “leader in the interventional radiology industry” with its buyout of J&J's cancer ablation company NeuWave. fiercebiotech.com/medtech/quantu…

The company said the issue is tied to 114 serious injuries and one death since the devices’ launch 12 years ago.

The FDA is flagging a high-risk issue with blood glucose monitors manufactured by Trividia Health fiercebiotech.com/medtech/fda-is…

Grail’s Galleri cancer blood test missed its primary endpoint in a major NHS trial fiercebiotech.com/medtech/grail-…

Danaher is snapping up patient monitoring medtech Masimo in a $9.9 billion deal aimed at strengthening its diagnostics portfolio fiercebiotech.com/medtech/danahe…

Study finds blood test can predict age of Alzheimer's onset fiercebiotech.com/medtech/study-…

One month after Integra LifeSciences recalled its wound and burn devices amid safety concerns, the medtech company is cutting jobs at the New Jersey site where they are made. fiercebiotech.com/medtech/integr…

Labcorp launches Roche's FDA-cleared Alzheimer's blood test fiercebiotech.com/medtech/labcor…

Langer-backed biotech looks to end cancer recurrence with surgical revolution fiercebiotech.com/biotech/langer…

Agilent companion diagnostic lands FDA nod alongside Keytruda's latest cancer approval fiercebiotech.com/medtech/agilen…

Bristol Myers and Evinova pen global development partnership fiercebiotech.com/cro/bristol-my…